The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030, pre

Category: Health

Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs Roots Analysis is pleased to announce the publication of its recent study, titled, “Microbial Contract Biomanufacturing Market, 2020-2030. The report features an extensive study of the current market landscape and future opportunities associated with the microbial contract biomanufacturing market. It features a detailed analysis of key drivers and trends related to this evolving domain. In addition to other elements, the study includes:  A detailed review of the current landscape of companies offering contract manufacturing services.  Elaborate profiles of key players that specialize in offering services for contract biomanufacturing.  A competitiveness analysis, highlighting key players engaged in microbial based contract manufacturing, featuring insightful pictorial summaries and representations.  An analysis of the partnerships and expansions that have been established in this domain, in the recent past.  A competitiveness analysis, highlighting key players engaged in microbial based contract manufacturing, featuring insightful pictorial summaries and representations.  A detailed proprietary 2×2 representation to assess the current market scenario  An analysis of the initiatives of big biopharma players engaged in this domain.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Product  API  FDF To request a sample copy / brochure of this report, please visit this - https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market/request-sample.html  Type of Biologic  Proteins  Enzymes  Growth Hormones  Antibody based Drugs  Others (plasmid DNA, probiotics, microbiome-based biologics)  Type of Microbial Expression System  Bacteria  Yeast  Others (Algae and fungi)  Scale of Operation  Commercial  Preclinical / Clinical  Type of End User  Small Companies  Mid-sized Companies  Large / Very Large Companies  Key Geographical Regions  North America  Europe  Asia Pacific  Middle East and North Africa Key companies covered in the report  AGC Biologics  Aldevron  BioVectra  EirGenix  Etinpro  Eurogentec  Northway Biotechpharma  Ology Bioservices  Porton Biopharma  Stelis Biopharma For additional details, please visit https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Drug Repurposing Service Providers Market, 2020 – 2030 2. Antibody Discovery Services and Platforms Market (3rd Edition), 2020-2030 3. Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020 - 2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis